Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 11-20 of 105 for

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. A Long Term Study Of Molecular And Structural Imaging In Atypical Alzheimer's Disease

    Rochester, MN

  2. Extracellular Impact Of Ultrasound-induced Blood-brain Barrier Disruption

    Rochester, MN

  3. A Study to Establish a Parkinson’s Disease (PD) Cohort using the Parkinson’s Progression Markers Initiative (PPMI)

    Scottsdale/Phoenix, AZ

  4. Droxidopa / Pyridostigmine In Orthostatic Hypotension

    Rochester, MN

  5. A Study Of Sonodynamic Therapy With SONALA-001 And Exablate 4000 Type 2.0 In Subjects With Progressive Or Recurrent Glioblastoma Multiforme (RGBM)

    Rochester, MN

  6. EMU

    Jacksonville, FL

  7. Testing The Addition Of An Anti-cancer Drug, Selinexor, To The Usual Chemotherapy Treatment (Temozolomide) For Brain Tumors That Have Returned After Previous Treatment

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. Cerebrospinal Fluid Biomarkers For Brain Tumors

    Rochester, MN

  9. Acute Modulation of Stereotyped High-Frequency Oscillations

    Rochester, MN

  10. Antineuronal Antibody Positivity Prevalence and Predictors in Epilepsy With Different Risks of Autoimmune Epilepsy

    Rochester, MN

.

Mayo Clinic Footer